Accueil / Tag Archives: Other Health

Tag Archives: Other Health

Bristol-Myers Squibb to Sell Manufacturing Facility in Swords, Ireland to SK Biotek Co., Ltd.

Friday, June 16th 2017 at 8:35am UTC SK Biotek is first Korean company to invest in pharmaceutical manufacturing in Ireland and anticipates further investment by adding R&D, marketing and additional manufacturing capabilities Bristol-Myers Squibb shifts manufacturing focus in Ireland to reflect growing biologics portfolio with ongoing investment in Cruiserath biologics …

Plus »

Cerveau Technologies, Inc. Announces FDA Acceptance of Investigational New Drug (IND) for Tau Imaging Agent MK-6240

Friday, June 16th 2017 at 12:08pm UTC MK-6240, licensed to Cerveau from Merck, is a next-generation imaging biomarker, intended to enhance assessment of the status of neurodegenerative disease, thereby enabling accelerated therapeutic development BOSTON–(BUSINESS WIRE)– Cerveau Technologies, Inc. today announced that the United States Food and Drug Administration has cleared …

Plus »

Covalon Announces Voting Results from 2017 Annual Meeting of Shareholders

Friday, June 16th 2017 at 9:00pm UTC MISSISSAUGA, Ontario–(BUSINESS WIRE)– Covalon Technologies Ltd. (the « Company » or « Covalon ») (TSXV: COV), an advanced medical technologies company, today announced the results of the matters voted upon at the Company’s 2017 Annual Meeting of shareholders held June 15, 2017. Shareholders voted in favour of …

Plus »

Extended Follow-Up Data Evaluating Opdivo (nivolumab) Shows Durable Response in Adult Patients with Relapsed or Progressed Classical Hodgkin Lymphoma

Friday, June 16th 2017 at 10:58am UTC Results show overall response rates of 65% or greater with median follow-up of at least 16 months, regardless of prior brentuximab vedotin therapies PRINCETON, N.J.–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) today announced extended follow-up data in which Opdivo (nivolumab) demonstrated responses in adult …

Plus »

California Life Sciences Association Applauds Gov. Brown & Legislature on Budget Agreement that Invests $10M in Precision Medicine

Thursday, June 15th 2017 at 11:39pm UTC SACRAMENTO, Calif. & SAN FRANCISCO & SAN DIEGO–(BUSINESS WIRE)– California Life Sciences Association (CLSA), the premier public policy advocacy and business leadership trade association representing California’s life sciences industry, today issued the following statement applauding the passage of California’s 2017-2018 budget that invests …

Plus »

Merck Becomes Member of the Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium (Paris)

Thursday, June 15th 2017 at 10:00am UTC PARIS & DARMSTADT, Germany–(BUSINESS WIRE)– Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium proudly announces today that Merck, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, becomes a member of the WIN Consortium. WIN is a network of …

Plus »

Merck devient membre du Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium (Paris)

Thursday, June 15th 2017 at 10:00am UTC PARIS & DARMSTADT, Allemagne–(BUSINESS WIRE)– Le Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium est fier d’annoncer que Merck, dont les activités biopharmaceutiques sont exercées sous la dénomination EMD Serono aux États-Unis et au Canada, devient membre de WIN. Le consortium WIN …

Plus »

Merck se convierte en miembro de la Worldwide Innovative Network in Personalized Cancer Medicine – WIN Consortium (Paris)

Thursday, June 15th 2017 at 10:00am UTC PARIS & DARMSTADT, Germany–(BUSINESS WIRE)– Worldwide Innovative Network in Personalized Cancer Medicine (Red innovadora mundial en medicina oncológica personalizada) – WIN Consortium se enorgullece en anunciar hoy que Merck, que opera su negocio en el sector biofarmacéutico como EMD Serono en EE. UU. …

Plus »

Viamet to Participate in Antifungal Panel Discussion at the 2017 BIO International Convention

Wednesday, June 14th 2017 at 12:00pm UTC RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)– Viamet Pharmaceuticals, Inc. today announced that Robert Schotzinger, M.D., Ph.D., President and CEO of Viamet, will be participating in a panel discussion on emerging issues and unmet needs in antifungal development at the 2017 BIO International Convention, taking …

Plus »

LEO Science & Tech Hub Announce New Collaboration to Develop Technology for Minimally-Invasive Dermal Biomarker Assessment

Thursday, June 15th 2017 at 12:30pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– LEO Science & Tech Hub today announced a two-year collaboration with the Karp Lab at Brigham and Women’s Hospital (BWH) to develop minimally-invasive technology to advance dermal biomarker assessment. The Karp Lab, led by Jeffrey Karp, PhD, at BWH focuses …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...